0I1B Enovis Corporation
18.33USD-1.77%Mkt Cap: —P/E: —Today
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconst…
Industry Peers
MachineryKey Statistics
Company
Market Cap—
Enterprise Value2.41B USD
Revenue (TTM)2.30B USD
Gross Profit1.41B USD
Net Income (TTM)-1.10B USD
Revenue/Share40.07 USD
Last Price18.33 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees7.8K
CountryGB
SectorIndustrials
IndustryMachinery
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA6.33
EV/Revenue1.05
P/S—
P/B0.69
EPS (TTM)—
EPS (Forward)—
52W Range
17.396% of range33.45
52W High33.45 USD
52W Low17.39 USD
Profitability
Gross Margin61.32%
Oper. Margin4.18%
EBITDA Margin16.54%
Profit Margin-47.97%
ROE-54.14%
ROA1.20%
Growth
Revenue Growth3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF270.10M USD
CapEx (TTM)—
FCF Margin8.10%
FCF Yield—
Net Debt1.36B USD
Net Debt/EBITDA3.57
Balance Sheet
Debt/Equity92.56
Current Ratio1.99
Quick Ratio0.74
Book Value/Sh25.61 USD
Cash/Share0.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.333333:1
Split DateApr 5, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float52.76M
Insiders1.64%
Institutions124.43%
Technical
SMA 5056.19 (-67.4%)
SMA 20054.68 (-66.5%)
Beta1.43
S&P 52W Chg14.58%
Avg Vol (30d)418
Avg Vol (10d)36
Technical Indicators
RSI (14)40.5
MACD-1.1470
MACD Signal-1.3161
MACD Hist.+0.1690
BB Upper19.97 USD
BB Middle18.61 USD
BB Lower17.25 USD
BB Width14.61%
ATR (14)0.8168 USD
Vol Ratio (20d)0.02x